Antigenic Challenge
Antigenic Challenge - Related Videos
08:38
Overcoming Unresponsiveness in Experimental Autoimmune Encephalomyelitis (EAE) Resistant Mouse Strains by Adoptive Transfer and Antigenic Challenge
0 Views •
Cited by 1 •
2012
Certain mouse strains are able to resist induction of experimental autoimmune encephalomyelitis (EAE) with myelin basic protein. Described here is a simple immunization protocol that reverses the unresponsiveness and induces paralytic disease in several typical EAE resistant mouse stains.
06:57
Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
0 Views •
Cited by 9 •
2016
In this antigen-driven colitis model, OT-II CD4+ T cells expressing a red fluorescent protein were adoptively transferred into RAG-/- mice that express a green fluorescent protein in mononuclear phagocytes (MPs). The hosts were challenged with Escherichia coli (E.coli) expressing the ovalbumin protein (OVA) fused to a cyan fluorescent protein (CFP).
05:09
Repetitive Tumor Challenge Assay: An In Vitro Culture Assay to Evaluate Chimeric Antigen Receptor (CAR) T Cells for Repetitive Tumor Killing Potential
0 Views •
2025
In this video, we demonstrate the repetitive tumor challenge assay to evaluate the CAR T cells’ repetitive tumor killing potential during high tumor cell loads. Further, the CAR T cells can be analyzed using flow cytometry to determine the different subpopulations of CAR T cells in the sample.
01:20
Challenges in Global Marketing
0 Views •
2025
Global marketing is a complex field where businesses encounter a range of challenges as they expand into international markets. These challenges can stem from internal factors, such as strategic misalignment, communication breakdowns, and operational inefficiencies. Understanding and addressing these barriers is essential for companies aiming to establish a successful presence abroad. One of the primary obstacles is the development of non-country-specific marketing strategies. When businesses...
01:23
Market Challenger Strategies
0 Views •
2024
Market challengers use different strategies to disrupt industry leaders and gain market share by leveraging their strengths and market insights. One such strategy is the Full-Frontal Attack, where the challenger directly competes with the market leader by mirroring its product offerings, pricing, and promotional strategies. This approach requires significant financial and operational resources to match the leader in every aspect of the business. For example, Samsung has employed a Full-Frontal...
FAQs
The response begins when antigen-presenting cells process the introduced material and display resulting fragments on major histocompatibility complex molecules. T cells recognize these displayed fragments through antigen-specific interactions, providing a cellular readout of immune recognition. This step connects the encountered antigen with downstream coordination of B-cell proliferation, antibody production, and the development of immune memory.
Following antigen-specific immune activation, B cells proliferate and produce antibodies directed against the relevant antigen. Antibody titers, meaning measured antibody levels, provide one way to quantify this humoral response. Examining these levels alongside cellular responses helps distinguish whether an exposure generated measurable antibody production and supports comparisons among different immune conditions.
Comparing primary and secondary responses reveals how prior immune experience changes the response to a subsequent encounter. The comparison can include antigen-specific cellular activity, antibody titers, and pathogen control. Because immune memory is established through earlier exposure, this design helps researchers determine whether prior vaccination or challenge is associated with a stronger or more effective protective response.
Useful outcome measures include cellular immune responses, antibody titers, and the degree of pathogen control. These measurements address complementary questions: whether immune cells recognize the antigen, whether antibody production occurred, and whether the host limits infection. Interpreting them together provides a broader assessment than relying on a single indicator of immune activity.
A controlled antigenic challenge allows researchers to compare immune responses and pathogen control between subjects with different prior immunization or exposure histories. Measurements can show whether vaccination is associated with antigen-specific cellular activity, antibody production, immune memory, or improved control of the pathogen. Such findings help characterize protection and inform development of vaccines and related interventions.
In immunology and infection studies, challenge experiments connect molecular recognition with measurable host defense. Researchers can examine antigen presentation, T-cell activation, B-cell proliferation, antibody titers, memory, and pathogen control within the same investigative framework. This integrated view helps clarify mechanisms of immunity, compare host responses, and identify evidence relevant to vaccine and intervention development.